Lecture Notes on Multimode Immunology

Overview of Immune System and Pathogen Recognition

The lecture elucidates the mechanisms by which cells perceive and respond to infections, focusing on innate immunity. The critical aspect of this segment is understanding how the immune system identifies pathogen-associated molecular patterns (PAMPs) versus danger signals released from damaged tissues.

Key Terms and Concepts

  • Checkpoint Inhibitors: These are specific antibodies such as anti-PD1 and anti-CTLA4, which target immune checkpoints in therapy.

  • Pathogen Recognition Receptors (PRRs): These play a crucial role in identifying pathogens through various receptors that are present on both immune and non-immune cells. This includes Toll-like receptors and other types that recognize a range of PAMPs from bacteria, fungi, and viruses.

Pathogen Recognition

  • PRRs: These include Toll-like receptors (TLRs), C-type lectins, and NOD-like receptors, which identify PAMPs present in microbial entities like bacteria and viruses. Many immune cells (macrophages, neutrophils) use these receptors to detect pathogens, but importantly, it’s emphasized that all cell types can sense infections, even those not traditionally categorized as immune cells (e.g., epithelial and endothelial cells).

  • PAMPs: These are molecular structures on pathogens that are recognized by PRRs, which do not exist in mammals. Examples include bacterial cell walls (like LPS), fungal components (like beta-glucans), and viral nucleic acids (like DNA and RNA).

Immune Response Mechanisms

  • Direct Sensing: Cells can recognize pathogens using their PRRs directly through recognizing PAMPs and also by gauging tissue damage, which indicates an infection.

  • Danger Signals: These are cellular signals that arise upon tissue damage (like ATP, uric acid) and can induce an immune response. They are distinguished from the direct detection of pathogens by sensing damage caused by pathogens rather than recognizing the pathogens themselves.

Signaling Pathways

  1. Receptor Engagement: Upon pathogen or damage recognition, these PRRs bind to their ligands triggering intracellular signaling pathways which are often similar but lead to diverse cellular responses.

  2. Cytokine Release: Cell activation leads to the production of inflammatory cytokines, facilitating communication between cells and orchestrating a coordinated immune response.

  3. Ubiquitination: A central mechanism in the signaling process is the modification of proteins through ubiquitination, particularly K63-linked ubiquitination, which plays a crucial role in activating NF-kappaB (NF-κB) pathways involved in inflammation.

  4. NF-κB and MAPK Pathways: These pathways are activated leading to gene expression changes, primarily inducing pro-inflammatory cytokines like IL-1, TNF-α, and IL-6, which determine the type of immune response initiated.

Types of Immune Responses

  • Th1 Response: Typically activated during intracellular infections like viruses and some bacteria.

  • Th2 Response: Engaged during infections with multicellular parasites.

  • Th17 Response: Important for combating extracellular bacteria and fungi.
    The lecture implies that distinguishing signals from various pathogens during infections rely on both receptors present and the specific immune cells involved.

Complex Interactions and Adaptations

The subtle complexities of how immune responses are tailored to specific pathogens are still being studied and involve many different signaling molecules and proteins that can vary by cell type. Overall, the ability to respond differently to various classes of pathogens is a multi-faceted process involving unique receptors, paths of signal transduction, cellular environments, and types of recognition molecules.

Conclusion

The immune system's ability to recognize and respond to a vast array of pathogens relies on the interplay between various receptors, the nature of the recognized material, and the intrinsic signaling pathways that kick-start a tailored immune response. Understanding these mechanisms is foundational for advancing therapeutic approaches to modulate these immune pathways for better clinical outcomes.